2d
GlobalData on MSNRegeneron’s macular oedema therapy shows promise in Phase III trialIn the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.
In this CE activity, experts in the field will assess how advances in imaging and new therapies for the management of geographic atrophy secondary ... and management of retinal vein occlusion.
The continued evolution of treatment protocols and imaging modalities for the management of retinal diseases offer ... for the management of geographic atrophy secondary to age-related macular ...
Novel Intravitreal Injections: Faricimab and Aflibercept 8mg for the Treatment of Retinal Diseases Video content above is prompted by the following: What are the key considerations for the surgical ...
Newly appointed US Secretary of State Marco Rubio raised the issue of “irregular immigration” in his very first meeting with External Affairs Minister S Jaishankar in Washington DC Wednesday. While ...
US Secretary of State Marco Rubio will hold his first bilateral meeting with External Affairs Minister S Jaishankar in Washington later Tuesday. S Jaishankar is here at the invitation of the US ...
External Affairs Minister S Jaishankar and Marco Rubio, the new US secretary of state, will hold a bilateral meeting on Tuesday, sources told News18. Both ministers will also attend the Quad foreign ...
A 4-time WWE Champion has talked about his health issues and revealed that he has atrophy in both arms and is in constant pain. The star made the revelation in a recent interview. Kurt Angle was ...
"We have been able to demonstrate that Ziapin2 can regenerate the physiological antagonism between the ON retinal neurons, which signal the presence of light, and the OFF neurons, which signal the ...
Jaishankar said they discussed the progress in their bilateral cooperation and took stock of Quad's developments. In a post on X, he said, "Good to meet with FM Takeshi Iwaya of Japan. Reviewed the ...
Our goal is to confirm the safety of our drug candidate to then rapidly move into a phase II proof-of-concept study, to demonstrate transferrin’s ability to protect retinal cells from atrophy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results